Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.410
-0.170 (-3.71%)
At close: Jan 31, 2025, 4:00 PM
4.400
-0.010 (-0.23%)
After-hours: Jan 31, 2025, 6:50 PM EST

Vanda Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for VNDA stock have an average target of 15.5, with a low estimate of 13 and a high estimate of 18. The average target predicts an increase of 251.47% from the current stock price of 4.41.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $13 $15.5 $18 $18
Change +194.78% +251.47% +308.16% +308.16%

Analyst Ratings

The average analyst rating for VNDA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Aug '24Sep '24Oct '24Nov '24Dec '24Jan '25
Strong Buy 001111
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 112222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +308.16% Jan 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +308.16% Jan 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +308.16% Dec 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$18
Strong Buy Initiates $18 +308.16% Oct 31, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$11$13
Buy Maintains $11$13 +194.78% Aug 1, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
203.43M
from 192.64M
Increased by 5.60%
Revenue Next Year
290.60M
from 203.43M
Increased by 42.85%
EPS This Year
-0.33
from 0.04
EPS Next Year
0.21
from -0.33
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
227.19M248.17M268.68M254.38M192.64M203.43M290.60M336.30M
Revenue Growth
17.64%9.23%8.27%-5.32%-24.27%5.60%42.85%15.73%
EPS
2.110.420.580.110.04-0.330.211.03
EPS Growth
339.58%-80.09%38.10%-81.03%-63.64%--396.73%
Forward PE
------21.264.28
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 215.4M 391.4M 535.2M
Avg 203.4M 290.6M 336.3M
Low 190.7M 230.3M 194.0M

Revenue Growth

Revenue Growth 202420252026
High
11.8%
92.4%
84.2%
Avg
5.6%
42.9%
15.7%
Low
-1.0%
13.2%
-33.2%

EPS Forecast

EPS 202420252026
High -0.22 1.38 2.12
Avg -0.33 0.21 1.03
Low -0.37 -0.41 -

EPS Growth

EPS Growth 202420252026
High - -
922.7%
Avg - -
396.7%
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.